High dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

BACKGROUND: Ursodeoxycholic acid (UDCA) in a dose of 28–30 mg/kg/day increases the likelihood of clinical deterioration of primary sclerosing cholangitis (PSC) patients. AIM: Our aim was to compare the risk of adverse clinical endpoints in patients with varying disease status. METHODS: We reviewed r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Imam, Mohamad H., Sinakos, Emmanouil, Gossard, Andrea A., Kowdley, Kris V., Luketic, Velimir A. C., Harrison, M. Edwyn, McCashland, Timothy, Befeler, Alex S., Harnois, Denise, Jorgensen, Roberta, Petz, Jan, Keach, Jill, DeCook, Alisha C., Enders, Felicity, Lindor, Keith D.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752281/
https://ncbi.nlm.nih.gov/pubmed/21957881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2011.04863.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker